The 11th APACMed MedTech Forum (MTF), Asia’s most influential gathering of MedTech leaders, is being held on Sept 16 and 17, 2025 in New Delhi. Marking a defining moment for India’s healthcare and innovation landscape, it was organised by the Asia Pacific Medical Technology Association (APACMed).
The two-day forum brought together over 500 participants, including senior government officials, global CEOs, regulators, and innovators, to position India as a global hub for MedTech innovation, manufacturing, and regulatory excellence. Themed “Swastha Bharat – A Healthier India, Together,” the event aligned with India’s vision of Viksit Bharat 2047 and Healthcare Vision 2030, the event marked the presence of the titans of the industry, as well as key legislators and policy makers of the country.
The forum witnessed resolute participation from key government leaders, including JP Nadda, Union Minister of Health & Family Welfare; Anupriya Patel, Minister of State, Ministry of Health and Family Welfare and Ministry of Chemicals; Dr V K Paul - Member - Niti Aayog graded the inaugural session.
Amit Agrawal, Secretary, Department of Pharmaceuticals; BVR Subramanyam - CEO Niti Aayog; Dr Rajiv Bahl, Secretary, Department of Health Research & DG, ICMR; Parvinder Maini, Scientific Secretary - PSA.
Nadda remarked, “The MedTech sector is one of the key pillars of health transformation - whether through diagnostics, advanced devices, digital health or AI driven solutions - MedTech has the power to make healthcare more accessible, efficient and affordable for all citizens. The MedTech Forum 2025 is closely aligned with Prime Minister Narendra Modi's vision for Viksit Bharat 2047.”
Global MedTech leaders, including Kevin Lobo (Chairman & CEO, Stryker), Gary S. Guthart (CEO, Intuitive Surgical), and Katarzyna Mazur-Hofsäß (CEO, Fresenius Medical Care), emphasised India’s strategic importance as a priority market for innovation and investment. Discussions explored India’s evolution from a cost-effective manufacturing hub to a global leader in high-value innovation, supported by its vibrant startup ecosystem, advanced R&D capabilities, and robust talent pool.
A key highlight was the Regulators Forum, which convened leaders from across the Asia Pacific to discuss how regulatory agility can drive innovation in emerging technologies like AI, digital health, and personalized medicine. Leadership dialogues also focused on India’s transition from import dependency to self-reliance, with discussions on scaling advanced manufacturing, fostering innovation, and ensuring equitable access to healthcare technologies.
The forum underscored India’s ambition to achieve a $50 billion MedTech market by 2030, driven by initiatives like the National Medical Device Policy and Production Linked Incentive schemes.